Smart Pills and Drugs Delivery Systems Market Size | 2031
Smart Pills and Drugs Delivery Systems Market Size | 2031
Segments - Smart Pills and Drugs Delivery Systems Market by Product (Connected Inhalers, Connected Wearable Injectors, Connected Autoinjectors, Connected Pen Injectors, Add-on-sensors, and Others), Delivery Mode (Injectable, Implanted, Oral, Inhalation, and Others), Application (Endoscopy, Patient Monitoring, and Others), End-user (Clinics, Hospitals, Home Care, Ambulatory Care, Research Centers, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 – 2031
Upcoming
| Report ID :HC-5054
| 4.6 Rating
| 60 Reviews
| 191 Pages
| Format :
Report Description
The global smart pills and drugs delivery systems market size was USD XX Bn in 2022 and is likely to reach USD XX Bn by 2031, expanding at a CAGR of XX% during 2023–2031. The market growth is attributed to the increasing preference of patients for advanced drug delivery systems and rising demand for personalized medicines.
Smart pills and drugs refer to mini electronic devices that are equipped with sensors. These pills and drugs are designed in the mold of capsules to perform highly advanced functions in the human body such as imaging, sensing, and drug delivery. A delivery system for those pills and drugs employs smart technology for efficient delivery to a targeted area, which is widely used in the diagnosis and therapeutics of numerous chronic and acute diseases.
Smart pills and drug delivery systems use different formulations, technologies, and approaches to deliver drugs to a specific area. These drugs are released at a proper rate as per need, which reduces dosage frequency and potential side effects. It helps enhance the safety and efficacy of drugs by delivering them to a specific place in the body and improving ease of administration.
The market report finds that the COVID-19 pandemic propelled the market due to the rising requirement for monitoring patients suffering from COVID-19. However, the demand from the research and biotech sector has increased to test the effectiveness of the COVID-19 vaccines and drugs, which boosted the market.
Smart Pills and Drugs Delivery Systems Market Dynamics
Major Drivers
Increasing demand for quick diagnosis is expected to drive the market during the forecast period. Smart pills and drugs are released to a targeted area that evaluates patients’ health quickly, which helps to decide prescribe medications at an early stage to avoid long-term exposure to disease. Furthermore, the rising demand for minimally invasive surgeries is likely to propel the market.
Rising prevalence of chronic diseases is also driving the market. Chronic diseases require long-term treatment with proper monitoring to improve patient outcomes. Thus, the demand for reliable clinical testing and targeted drug delivery solutions has increased, thus fueling the market.
Existing Restraints
Smart pills are advanced technology that utilizes sophisticated systems and software for manufacturing, which requires a high initial amount. Thus, the high cost of smart pills limits the market to a certain level. Furthermore, the lack of awareness among the population regarding smart pills and drugs is expected to hamper the market.
Emerging Opportunities
Growing advances in nanotechnology and the rising investments in R&D by biotech and pharmaceutical companies create immense opportunities in the market. The incorporation of digital pathology and digital dictation increases the safety and efficacy of disease diagnostics. Thus, prominent players are focusing on improving the safety and efficacy of smart pills. Furthermore, the increasing FDA approvals for novel drugs is likely to fuel the market.
Scope of Smart Pills and Drugs Delivery Systems Market Report
The market report includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Smart Pills and Drugs Delivery Systems Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2022 |
|
Historic Data |
2016–2021 |
|
Forecast Period |
2023–2031 |
|
Segmentation |
Product (Connected Inhalers, Connected Wearable Injectors, Connected Autoinjectors, Connected Pen Injectors, Add-on-sensors, and Others), Delivery Mode (Injectable, Implanted, Oral, Inhalation, and Others), Application (Endoscopy, Patient Monitoring, and Others), and End-user (Clinics, Hospitals, Home Care, Ambulatory Care, Research Centers, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Abbott; Adherium; BD; Novo Nordisk A/S; Amiko Digital Health Limited; BIOCORP; CeQur Simplicity; Cognita Labs; E3D Elcam Drug Delivery Devices; H&T Presspart Manufacturing Ltd; HCmed Innovations Co., Ltd.; Boston Scientific Corporation; Medtronic; Microchip Technology Inc; Novartis AG; Koninklijke Philips N.V; Stryker; FUJIFILM Holdings Corporation; PENTAX Medical; CapsoVision; and Medimetriks Pharmaceuticals, Inc. |
Smart Pills and Drugs Delivery Systems Market Segment Insights
Product Segment Analysis
Based on product, the smart pills and drugs delivery systems market is segregated into connected inhalers, connected wearable injectors, connected autoinjectors, connected pen injectors, add-on-sensors, and others. The connected wearable injectors segment accounted for a large share of the market in 2021 and is expected to generate a key share of the market during the projection period, owing to the increasing concerns over needle stick injuries. It precisely delivers medications over fixed or variable periods of time. Rising demand for continuous health monitoring is likely to boost the segment.
Delivery Mode Segment Analysis
On the basis of delivery mode, the market is fragmented into injectable, implanted, oral, inhalation, and others. The injectable segment is anticipated to expand at a significant growth rate in the coming years, as it reduces side effects by controlling the release rate. It reduces fluctuations in plasma drug levels and improves patient compliance with safety and efficacy. The segment growth is further attributed to the growing need for reducing overdosage.
The implanted segment is estimated to grow at a rapid pace during the projected period, owing to the rising requirement for targeted drug delivery systems. In implanted mode, the drugs can be directly released to the specific area to achieve better results.
Application Segment Analysis
Based on application, the smart pills and drugs delivery systems market is divided into endoscopy, patient monitoring, and others. The patient monitoring segment is anticipated to register a robust growth rate during the forecast period, due to the rising prevalence of chronic diseases. Patients with chronic diseases require regular monitoring to keep track of their health condition, which reduces the time for a regular health checkup and improves their medical conditions.
On the other hand, the endoscopy segment is expected to grow at a considerable CAGR, due to the rising demand for accurate diagnosis. This growth is further attributed to the increasing demand for the diagnosis of gastrointestinal problems at an early stage.
End-User Segment Analysis
On the bases of end-user, the market is segmented into clinics, hospitals, home care, ambulatory care, research centers, and others. The research centers segment is estimated to expand at a significant growth rate during the projected period due to the ongoing R&D activities for developing and improving the products. However, smart pills and drugs are widely used in drug discovery to determine the side effects.
Regional Analysis
In terms of region, the global smart pills and drugs delivery systems market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is projected to dominate the market during the forecast period, due to its well-developed healthcare infrastructure. Furthermore, rising funding in R&D by government and private organizations and the growing acceptance of advanced technology are likely to boost the market.
The market in Asia Pacific is expected to grow quickly in the coming years, owing to the rising government initiatives towards improving healthcare infrastructure. The rapid expansion of medical tourism in emerging countries and the growing prevalence of chronic diseases in the region is likely to propel the market.
Segments
The global smart pills and drugs delivery systems market has been segmented on the basis of
Product
- Connected Inhalers
- Connected Wearable Injectors
- Connected Autoinjectors
- Connected Pen Injectors
- Add-on-sensors
- Others
Delivery Mode
- Injectable
- Implanted
- Oral
- Inhalation
- Others
Application
- Endoscopy
- Patient Monitoring
- Others
End-user
- Clinics
- Hospitals
- Home Care
- Ambulatory Care
- Research Centers
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Abbott
- Adherium
- BD
- Novo Nordisk A/S
- Amiko Digital Health Limited
- BIOCORP
- CeQur Simplicity
- Cognita Labs
- E3D Elcam Drug Delivery Devices
- H&T Presspart Manufacturing Ltd
- HCmed Innovations Co., Ltd.
- Boston Scientific Corporation
- Medtronic
- Microchip Technology Inc
- Novartis AG
- Koninklijke Philips N.V
- Stryker
- FUJIFILM Holdings Corporation
- PENTAX Medical
- CapsoVision
- Medimetriks Pharmaceuticals, Inc.
Competitive Landscape
Key players competing in the global smart pills and drugs delivery systems market are Abbott; Adherium; BD; Novo Nordisk A/S; Amiko Digital Health Limited; BIOCORP; CeQur Simplicity; Cognita Labs; E3D Elcam Drug Delivery Devices; H&T Presspart Manufacturing Ltd; HCmed Innovations Co., Ltd.; Boston Scientific Corporation; Medtronic; Microchip Technology Inc; Novartis AG; Koninklijke Philips N.V; Stryker; FUJIFILM Holdings Corporation; PENTAX Medical; CapsoVision; and Medimetriks Pharmaceuticals, Inc.
These companies have adopted development strategies including partnerships, acquisitions, mergers, collaboration, product launches, and production expansion to expand their consumer base worldwide. For instance,
- In March 2022, Novo Nordisk A/S launched NovoPen 6 and NovoPen Echo Plus for people with diabetes. These smart insulin pens automatically record insulin dose information regarding each injection.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Smart Pills and Drugs Delivery Systems Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Smart Pills and Drugs Delivery Systems Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Smart Pills and Drugs Delivery Systems Market - Supply Chain
4.5. Global Smart Pills and Drugs Delivery Systems Market Forecast
4.5.1. Smart Pills and Drugs Delivery Systems Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Smart Pills and Drugs Delivery Systems Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Smart Pills and Drugs Delivery Systems Market Absolute $ Opportunity
5. Global Smart Pills and Drugs Delivery Systems Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Applications
5.3.1. Endoscopy
5.3.2. Patient Monitoring
5.3.3. Others
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Smart Pills and Drugs Delivery Systems Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by End Users
6.3.1. Clinics
6.3.2. Hospitals
6.3.3. Home Care
6.3.4. Ambulatory Care
6.3.5. Research Centers
6.3.6. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Smart Pills and Drugs Delivery Systems Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Smart Pills and Drugs Delivery Systems Demand Share Forecast, 2019-2026
8. North America Smart Pills and Drugs Delivery Systems Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Applications
8.4.1. Endoscopy
8.4.2. Patient Monitoring
8.4.3. Others
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by End Users
8.7.1. Clinics
8.7.2. Hospitals
8.7.3. Home Care
8.7.4. Ambulatory Care
8.7.5. Research Centers
8.7.6. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Smart Pills and Drugs Delivery Systems Demand Share Forecast, 2019-2026
9. Latin America Smart Pills and Drugs Delivery Systems Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Applications
9.4.1. Endoscopy
9.4.2. Patient Monitoring
9.4.3. Others
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by End Users
9.7.1. Clinics
9.7.2. Hospitals
9.7.3. Home Care
9.7.4. Ambulatory Care
9.7.5. Research Centers
9.7.6. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Smart Pills and Drugs Delivery Systems Demand Share Forecast, 2019-2026
10. Europe Smart Pills and Drugs Delivery Systems Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Applications
10.4.1. Endoscopy
10.4.2. Patient Monitoring
10.4.3. Others
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by End Users
10.7.1. Clinics
10.7.2. Hospitals
10.7.3. Home Care
10.7.4. Ambulatory Care
10.7.5. Research Centers
10.7.6. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Smart Pills and Drugs Delivery Systems Demand Share Forecast, 2019-2026
11. Asia Pacific Smart Pills and Drugs Delivery Systems Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Applications
11.4.1. Endoscopy
11.4.2. Patient Monitoring
11.4.3. Others
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by End Users
11.7.1. Clinics
11.7.2. Hospitals
11.7.3. Home Care
11.7.4. Ambulatory Care
11.7.5. Research Centers
11.7.6. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Smart Pills and Drugs Delivery Systems Demand Share Forecast, 2019-2026
12. Middle East & Africa Smart Pills and Drugs Delivery Systems Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by Applications
12.4.1. Endoscopy
12.4.2. Patient Monitoring
12.4.3. Others
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Smart Pills and Drugs Delivery Systems Market Size and Volume Forecast by End Users
12.7.1. Clinics
12.7.2. Hospitals
12.7.3. Home Care
12.7.4. Ambulatory Care
12.7.5. Research Centers
12.7.6. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Smart Pills and Drugs Delivery Systems Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Smart Pills and Drugs Delivery Systems Market: Market Share Analysis
13.2. Smart Pills and Drugs Delivery Systems Distributors and Customers
13.3. Smart Pills and Drugs Delivery Systems Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Abbott
13.4.2. Adherium
13.4.3. BD
13.4.4. Novo Nordisk A/S
13.4.5. Amiko Digital Health Limited
13.4.6. BIOCORP
13.4.7. CeQur Simplicity
13.4.8. Cognita Labs
13.4.9. E3D Elcam Drug Delivery Devices
13.4.10. H&T Presspart Manufacturing Ltd
13.4.11. HCmed Innovations Co., Ltd.
13.4.12. Boston Scientific Corporation
13.4.13. Medtronic
13.4.14. Microchip Technology Inc
13.4.15. Novartis AG
13.4.16. Koninklijke Philips N.V
13.4.17. Stryker
13.4.18. FUJIFILM Holdings Corporation
13.4.19. PENTAX Medical
13.4.20. CapsoVision
13.4.21. Medimetriks Pharmaceuticals, Inc.
Methodology
Related Reports
Some other reports from this category!
Our Clients
